In Brief This Week: Eurogentec; NuGen Technologies; Orchid Cellmark | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Eurogentec this week said that its Eurogentec North America subsidiary has received ISO 13485:2003 certification for the production and sale of oligonucleotides for the in vitro diagnostics market. The firm said that it is now the sole custom oligonucleotide contract manufacturing organization to be fully cGMP compliant and have ISO 13485 certified cleanroom sites in North America, Europe, and Asia.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.